24 research outputs found
HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know
Full text linkThe use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis
No full textCutaneous papillomavirus infection in patients with rheumatoid arthritis or systemic lupus erythematosus. A case-control study
No full text
Vaccination and Inflammatory Arthritis: Overview of Current Vaccines and Recommended Uses in Rheumatology
No full text
Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs
No full textA streptavidin variant with slower biotin dissociation and increased mechanostability.
No full textStreptavidin binds biotin conjugates with exceptional stability but dissociation does occur, limiting its use in imaging, DNA amplification and nanotechnology. We identified a mutant streptavidin, traptavidin, with more than tenfold slower biotin dissociation, increased mechanical strength and improved thermostability; this resilience should enable diverse applications. FtsK, a motor protein important in chromosome segregation, rapidly displaced streptavidin from biotinylated DNA, whereas traptavidin resisted displacement, indicating the force generated by Ftsk translocation
